The RET Receptor Is Linked to Stress Response Pathways
Total Page:16
File Type:pdf, Size:1020Kb
[CANCER RESEARCH 64, 4453–4463, July 1, 2004] The RET Receptor Is Linked to Stress Response Pathways Shirley M. Myers and Lois M. Mulligan Division of Cancer Biology and Genetics, Queen’s Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada ABSTRACT viewed in Ref. 13). Furthermore, rearrangements of RET, resulting in juxtaposition of the RET kinase domain with a dimerization domain RET is a transmembrane receptor required for the development of from any of several other proteins, occur somatically in papillary neuroendocrine and urogenital cell types. Activation of RET has roles in cell growth, migration, or differentiation, yet little is known about the gene thyroid carcinoma (14). In each case, these mutations result in acti- expression patterns through which these processes are mediated. We have vation of the RET receptor, leading to inappropriate and/or increased generated cell lines stably expressing either the RET9 or RET51 protein RET-mediated signal transduction and resultant cell proliferation and isoforms and have used these to investigate RET-mediated gene expres- tumorigenesis. sion patterns by cDNA microarray analyses. As seen for many oncogenes, Activation of RET, either by ligand or through specific mutations, we identified altered expression of genes associated generally with cell– results in phosphorylation of multiple tyrosine residues that, in turn, cell or cell-substrate interactions and up-regulation of tumor-specific interact with specific adaptor molecules to trigger downstream sig- transcripts. We also saw increased expression of transcripts normally naling. Four of the tyrosines phosphorylated on RET activation, associated with neural crest or other RET-expressing cell types, suggesting these genes may lie downstream of RET activation in development. The tyrosines 905, 1015, 1062, and 1096, have been well characterized, most striking pattern of expression was up-regulation of stress response and are known to interact with a number of adaptor molecules to genes. We showed that RET expression significantly up-regulated the stimulate signaling through phosphatidylinositol kinase (PI3K)/AKT, genes for heat shock protein (HSP) 70 family members, HSPA1A, PLC-␥, RAS/extracellular signal-regulated kinase (ERK), p38MAPK, HSPA1B, and HSPA1L. Other members of several HSP families and c-Jun NH2-terminal kinase (JNK), and ERK5 pathways (15–19). In HSP70-interacting molecules that were associated with stress response response to these signals, cell type-specific responses are initiated that protein complexes involved in protein maturation were also specifically implement the varied functional roles of RET. An additional level of up-regulated by RET, whereas those associated with the roles of HSP70 in protein degradation were down-regulated or unaffected. The major mech- complexity of RET signaling is added by alternative splicing of the anism of stress response induction is activation of the heat shock tran- RET gene (20), which leads to functionally distinct RET isoforms, scription factor HSF1. We showed that RET expression leads to increased termed RET9 and RET51. These isoforms differ in their COOH- HSF1 activation, which correlates with increased expression of stress terminal amino acids, having either 9 or 51 unique residues, and have response genes. Together, our data suggest that RET may be directly distinct transforming and differentiative potentials in vitro (21, 22). In responsible for expression of stress response proteins and the initiation of transgenic mice, animals expressing only the RET9 isoform are viable stress response. and appear normal, whereas monoisoformic RET51 animals have kidney dysplasia and lack enteric ganglia (23). These differences INTRODUCTION likely reflect differences in signaling potential of these RET isoforms. An additional phosphotyrosine, Y1096, present only in RET51, has The RET proto-oncogene encodes a receptor tyrosine kinase re- been shown to bind GRB2, activating PI3K and RAS/MAPK path- quired for normal development of the kidney, peripheral, and central ways (24–27). In addition, RET9 and RET51 differ in protein inter- nervous systems, and of spermatogonia (1–3). RET has been impli- actions with phosphotyrosine 1062, which is the last amino acid cated in cell type-specific processes including cell proliferation, mi- common to both isoforms and lies in different amino acid contexts in gration, and differentiation, and likely plays each of these roles in each protein (20). Tyrosine 1062 has been shown to act as a binding specific cells and at specific developmental time points. In neural cell site for multiple adaptor proteins including SHC, docking protein lineages, RET also plays an important role in cell survival, particu- (DOK)1, DOK4, DOK5, fibroblast growth factor receptor substrate 2 larly in response to environmental stresses (4–11). (FRS2), and insulin receptor substrate 1 (IRS1) (15, 26, 28–30); In normal cells, the RET receptor is activated by the binding of both however, the relative binding of these molecules to RET9 and to a circulating ligand and a cell surface-bound coreceptor. RET ligands RET51 varies both quantitatively and qualitatively. For example, SHC are members of the glial cell line-derived neurotrophic factor (GDNF) binds both RET9 and RET51 but, whereas RET51 binds only to the family (reviewed in Ref. 12). These molecules interact directly with SHC-PTB domain, RET9 can also bind through the SHC-SH2 domain coreceptors of the GDNF family receptors ␣ (GFR␣) proteins, which potentiating differences in the specific downstream interactions and/or are linked to the cell surface by glycosylphosphatidyl-inositol linkage, the magnitude of the signals transduced (26). and the resultant complexes bind to the RET receptor to activate Although many of the pathways through which RET transduces downstream signaling events. In addition, activating point mutations extracellular signals have been identified or predicted, little is known of RET have been identified in patients with multiple endocrine neoplasia type 2, an inherited cancer syndrome characterized by of the gene targets that are specifically modulated in response to medullary thyroid carcinoma and pheochromocytoma and are found receptor activation. In this study, we have used gene expression in a large proportion of sporadic medullary thyroid carcinoma (re- microarray analyses to evaluate targets of RET activation in an embryonic kidney-derived cell line. In addition to predictable targets involved in cell–cell interaction, cell proliferation, and neuroendo- Received 11/17/03; revised 3/17/04; accepted 4/30/04. Grant support: This work was supported by grants from the National Cancer Institute crine differentiation, our data suggest that activation of the RET of Canada and the Canadian Institutes of Health Research. receptor may specifically target genes for proteins integral to induc- The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with ible cellular stress response. This study may provide a direct link 18 U.S.C. Section 1734 solely to indicate this fact. between the up-regulation of heat shock proteins (HSPs), seen in Requests for reprints: Lois M. Mulligan, Queen’s Cancer Research Institute, Bot- terell Hall, Room 329, Queen’s University, Kingston, Ontario, Canada, K7L 3N6. Phone: many primary tumor types and as a neuroprotective event, and the (613) 533-6310; Fax: (613) 548-1348; E-mail: [email protected]. stimulation of receptor tyrosine kinase activity. 4453 Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 2004 American Association for Cancer Research. RET AND THE STRESS RESPONSE MATERIALS AND METHODS quence tags (ESTs) were obtained from the University Health Network Mi- croarray Centre. The EST content of the 1.7K array partially overlapped that Expression Constructs. Full-length human cDNAs encoding either the of the 19K array.1 Arrays were probed with differentially labeled cDNAs using 1072 amino acid (RET9) or the 1114 amino acid (RET51) isoforms of RET optimized protocols.2 Briefly, in a 40-l reaction, 10 g of total RNA was (31) were cloned into CH269, an episomal expression vector derived from reverse transcribed using Superscript II according to the manufacturer’s in- vector pCEP4 (Invitrogen, Burlington, ON, Canada) under the control of the Ј Ј structions (Invitrogen) with 3.75 M Anchored-T primer (5 -T20VN-3 ); cytomegalovirus promoter. The sequence of each construct was verified by dATP, dGTP, and dTTP (500 M each); and 50 M dCTP, 10 mM DTT, 1 ng restriction digestion, and direct sequencing (Mobix, Hamilton, ON, Canada). of control RNA (artificial Arabadopsis transcripts), and either 25 M Cy3- The GFR␣1 expression construct has been described previously (32, 33). dCTP or Cy5-dCTP (Mandel-NEN, Guelph, ON, Canada) at 42°C for 2–3h. Cell Culture and Transfection Experiments. E293, a transformed em- RNA was hydrolized and Cy5 and Cy3-labeled cDNA were combined, iso- bryonic kidney cell line, was maintained in DMEM, supplemented with 10% propanol precipitated, and resuspended in water. Labeled cDNAs were hybrid- fetal bovine serum, penicillin, streptomycin, and G418. For transient transfec- ized to cDNA microarrays in a medium consisting of DIG Easy Hyb solution tions, E293 cells were seeded into six-well plates and grown to approximately (Roche Applied Science, Laval, QC, Canada) containing 50 g of yeast tRNA 70–80%